Amie VanMorlan; M.D.
Dr. VanMorlan is currently a Assistant Professor of Child Health at the University of Missouri in Columbia, MO. Earlier, she was a Fellow in Pediatric Endocrinology at Children’s Mercy Hospital in Kansas City, MO. She is a member of the several Professional Societies including the Lawson-Wilkins Pediatric Endocrine Society and The Endocrine Society. Dr. VanMorlan is board certified in both General Pediatrics and Pediatric Endocrinology in the states of Missouri and Kansas. She has co-authored several publications: Tartar, DM., VanMorlan, A., and Zaghouani, H. (2009). Tregs/Th17 cells: Promiscuous Signals and Fear of Commitment? Immunotherapy. 1: 27-29; Tartar, DM., VanMorlan, A., Wan, X., Guloglu, BF., Jain, R., Haymaker, CL., Ellis, JS., Hoeman, CM., Cascio, JA., Dhakal, M., Oukka, M., and Zaghouani, H. (2010). FoxP3+RORyt+ T Helper Intermediates Display Suppressive Function Against Autoimmune Diabetes. J. Immunol. 184: 3377-3385; Ellis, JS., Guloglu, FB., Tartar, DM., Hoeman CM., Haymaker, CL., Cascio, JA., Wan, X., Dhakal, M., VanMorlan, A., Yahng, SH., Zaghouani, H. (2010). APCs expressing high levels of programmed death ligand 2 sustain the development of CD4 T cell memory. J. Immunol. 185 (6) : 3149-57; and Diabetes Mellitus Requiring Insulin in an Infant with Gene Mutations in MODY2/MODY4 Jamie Odem, BS, Amie VanMorlan, MD, Danita Rife, RN, APRN, Ethan Munzinger, BS, Sarah Violand, BS, and Bert Bachrach, MD, Division of Pediatric Endocrinology, University of Missouri-Columbia School of Medicine, One Hospital Drive, M743, Columbia, MO USA 65212, Pediatric Diabetes, Vol 10, No 8, 550 -553, (2009). Published Online: 10 June 2009. Dr. Van Morlan holds a B.S. degree in Chemistry from Rockhurst College in Kansas City, MO, and a M.D. degree from Saint Louis University College of Medicine in St. Louis, MO.